Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients
Corresponding Author
Christian Marth
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Department of Obstetrics and Gynecology, University Hospital, Anich-strasse 35, A-6020 Innsbruck, Austria. Fax: 43 512 504 3112Search for more papers by this authorGünther Weiss
Internal Medicine, University Hospital, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorAstrid Koza
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorGilbert Reibnegger
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorGünter Daxenbichler
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorAlain G. Zeimet
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorDietmar Fuchs
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorHelmut Wachter
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorOtto Dapunt
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorCorresponding Author
Christian Marth
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Department of Obstetrics and Gynecology, University Hospital, Anich-strasse 35, A-6020 Innsbruck, Austria. Fax: 43 512 504 3112Search for more papers by this authorGünther Weiss
Internal Medicine, University Hospital, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorAstrid Koza
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorGilbert Reibnegger
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorGünter Daxenbichler
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorAlain G. Zeimet
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorDietmar Fuchs
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorHelmut Wachter
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorOtto Dapunt
Department of Obstetrics and Gynecology, University of Innsbruck, Innsbruck, Austria
Search for more papers by this authorAbstract
Granulocyte colony-stimulating factor (G-CSF) and granulo-cyte-macrophage colony-stimulating factor (GM-CSF) have recently been introduced in the treatment of chemotherapy-induced neutropenia. Effects of these CSFs on the cellular immune system were evaluated in 38 neutropenic gynecological cancer patients during chemotherapy. In addition to restoring the leukocyte count, GM-CSF-to a greater extent than G-CSF—also induced neopterin, a sensitive marker of macro-phages activated by interferons. This effect was confirmed in vitro by investigating the effects of these CSFs on interferon-γ-mediated pathways in THP-1 human myelomonocytic cells. The results suggest activation of immune effector cells by GM-CSF. © 1994 Wiley-Liss, Inc.
References
- Fuchs, D., Hausen, A., Reibnegger, G. and Wachter, H., Automatized routine estimation of neopterin in human urine by HPLC on reversed phase. In: H. Wachter, H. C. Curtius and W. Pfleiderer (eds.), Clinical aspects of pteridines, Vol. 1, pp. 67–79, Walther de Gruyter, Berlin (1982).
- Hamilton, J., Colony stimulating factors, cytokines and monocyte-macrophages—some controversies. Immunol. Today, 14, 18–24 (1985).
- Hart, P. H., Whitty, G. A., Burgess, D. R. and Hamilton, J. A., Regulation by interleukin-3 of human monocyte pro-inflammatory mediators. Similarities with granulocyte-macrophage colony-stimulating factor. Immunology, 71, 76–82 (1990).
- Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J. and Wachter, H., Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J. exp. Med., 160, 310–316 (1984).
- Jones, T. C., The effects of rhGM-CSF on macrophage function. Europ. J. Cancer, 29A, 10–13 (1993).
- Marth, C., Weger, A., Müller-Holzner, E., Zeimet, A. G., Moncayo-Naveda, H., Daxenbichler, G., Reibnegger, G., Fuchs, D., Wachter, H. and Dapunt, O., The prognostic value of nuclear roundness and neopterin in ovarian cancer. Europ. J. Cancer, 29A, 1863–1868 (1993).
- Metcalf, D., The molecular biology and functions of the granulocyte-macrophage colony stimulating factors. Blood, 67, 257–267 (1986).
- Rappolee, D. A., Mark, D., Banda, M. J. and Werb, Z., Wound macrophages express TGF-alpha and other factors in vivo. Analysis by mRNA phenotyping. Science, 241, 708–712 (1988).
- Reibnegger, G., Bichler, A., Dapunt, O., Fuchs, D., Fuith, L. C., Hausen, A., Hetzel, H., Lutz, H., Werner, E. R. and Wachter, H., Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res., 46, 950–955 (1986).
- Reibnegger, G., Hetzel, H., Fuchs, D., Fuith, L. C., Hausen, A., Werner, E. R. and Wachter, H., Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Cancer Res., 47, 4977–4981 (1987).
- Reibnegger, G., Krainer, M., Herold, M., Ludwig, H., Wachter, H. and Huber, H., Predictive value of interleukin-6 and neopterin in patients with multiple myeloma. Cancer Res., 51, 6250–6253 (1991).
- Sisson, S. D. and Dinarello, C. A., Production of inlerleukin-1-alpha, interleukin-1β and tumor necrosis factor by human mononucleur cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood, 72, 1368–1374 (1988).
- Steward, W. P., Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet, 342, 153–157 (1993).
- Takahashi, G., Andrews, F. D. III, Lilly, M. B., Singer, J. W. and Alderson, M. R., Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood, 81, 357–364 (1993).
- Tarakhovsky, A., Zaichuk, T., Prassolov, V. and Butenko, Z. A., A 25-kDa polypeptide is the ligand for pl85neu and is secreted by activated macrophages. Oncogene, 6, 2187–2196 (1991).
- H. Wachter, D. Fuchs, A. Hausen, G. Reibnegger, G. Wliss, E. R. Werner and G. Werner-Felmayer, (eds.), Neopterin; biochemistry, methods, clinical application. Walter de Gruyter, Berlin (1991).
- Weiss, G., Fuchs, D., Hausen, A., Reibneggqer, G., Werner, E. R., Werner-Felmayer, G. and Wachter, H., Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hemalol., 20, 605–610 (1992).
- Welte, K., Bonilla, M. A., Gillio, A. P., Boone, T. C., Potter, G. K., Gabrilove, J. L., Moore, M. A. S., O'Reilly, R. J. and Souza, L. M., Recombinant human granulocyte colony-stimulating factor. J. exp. Med., 165, 941–948 (1987).
- Werner-Felmayer, G., Werner, E. R., Fuchs, D., Hausen, A., Reibnegger, G. and Wachter, H., Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res., 50, 2863–2867 (1990).
- Wing, E. J., Magee, D. M. and Whitesside, T. L., Recombinant human granulocyte-macrophage colony stimulating factor enhances monocyte cytoxicity and secretion of tumor necrosis factor and interferon in cancer patients, Blood, 73, 643–646 (1989).
- Zwierzina, H., Herold, M., Schöllenberger, S., Geissler, D. and Schmalzl, F., Detection of soluble IL-2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM-CSF. Brit. J. Haematol., 79, 438–443 (1991).